Metformin × glycemic control

ArticlePloS one2015

Comparative efficacy and safety of antidiabetic drug regimens added to metformin monotherapy in patients with type 2 diabetes: a network meta-analysis.

Elizabeth S Mearns et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedrandomised · 2015

Randomised comparison

Probably lowered glycemic control

−0.65−0.91 to −0.39

As reported

difference −0.65, 95% CI −0.91 to −0.39

One number in the abstract

the abstract, start to end

vs. dapagliflozin (change in HbA1c = -0.65, 95%CI -0.91, -0.39) would met

← favours treatmentfavours comparator →
could be chance
Glycemic control
−0.65−0.91 to −0.39
MetforminGlycemic control
1 / 3

65 papers cite itlatest 60 shown

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 25919293